Signal transduction pathway of interleukin-4 and interleukin-13 in human B cells derived from X-linked severe combined immunodeficiency patients

被引:96
作者
Izuhara, K
Heike, T
Otsuka, T
Yamaoka, K
Mayumi, M
Imamura, T
Niho, Y
Harada, N
机构
[1] KYUSHU UNIV,DEPT INTERNAL MED 1,HIGASHI KU,FUKUOKA 812,JAPAN
[2] KYOTO UNIV,DEPT PEDIAT,SAKYO KU,KYOTO 606,JAPAN
[3] RES INST TB,RES DEPT 1,BIOCHEM SECT,TOKYO 204,JAPAN
关键词
D O I
10.1074/jbc.271.2.619
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-4 (IL-4) and IL-13 are functionally similar cytokines. The functional IL-4 receptor (IL CR) consists of the IL-4R alpha chain (IL-4R alpha) and the IL-2R gamma chain (gamma(c)), which is shared by the IL-2, IL-7, IL-9, and IL-15 recep tors. The functional IL-13R is thought to involve the IL-4R alpha but not gamma(c). In this study, we have analyzed activation of members of the Janus tyrosine kinase (Jak) family and signal transducers and activators of transcription (STAT) 6 induced by IL-4 and IL-13 in Epstein-Barr virus-transformed B cells derived from two patients of X-linked severe combined immunodeficiency, who have mutations of the gamma(c) gene in the extracellular and intracellular domains. In these B cells, IL-4 failed to induce tyrosine phosphorylation of Jak3 and activation of STAT6, or activation of these molecules was significantly decreased compared with Epstein-Barr virus-transformed normal B cells. In contrast, IL-13 activated STAT6 in these cells as well as normal B cells. However, Jak3 was not activated by IL-13, even in normal B cells. These results clearly indicated that gamma(c) is essential for activation of Jak3 and STAT6 in the signal transduction pathway of IL-4 in human B cells and that IL-13 does not utilize gamma(c) but activates STAT6 through an alternative pathway, which is not impaired in B cells of X-linked severe combined immunodeficiency patients.
引用
收藏
页码:619 / 622
页数:4
相关论文
共 40 条
  • [1] INTERLEUKIN 2-INDUCED ACTIVATION OF JAK3 - POSSIBLE INVOLVEMENT IN SIGNAL-TRANSDUCTION FOR C-MYC INDUCTION AND CELL-PROLIFERATION
    ASAO, H
    TANAKA, N
    ISHII, N
    HIGUCHI, M
    TAKESHITA, T
    NAKAMURA, M
    SHIRASAWA, T
    SUGAMURA, K
    [J]. FEBS LETTERS, 1994, 351 (02) : 201 - 206
  • [2] X-LINKED SEVERE COMBINED IMMUNODEFICIENCY
    CONLEY, ME
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1991, 61 (02): : S94 - S99
  • [3] LYMPHOID DEVELOPMENT IN MICE WITH A TARGETED DELETION OF THE INTERLEUKIN-2 RECEPTOR-GAMMA CHAIN
    DISANTO, JP
    MULLER, W
    GUYGRAND, D
    FISCHER, A
    RAJEWSKY, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (02) : 377 - 381
  • [4] INTERLEUKIN-2 (IL-2) RECEPTOR-GAMMA CHAIN MUTATIONS IN X-LINKED SEVERE COMBINED IMMUNODEFICIENCY DISEASE RESULT IN THE LOSS OF HIGH-AFFINITY IL-2 RECEPTOR-BINDING
    DISANTO, JP
    DAUTRYVARSAT, A
    CERTAIN, S
    FISCHER, A
    DESAINTBASILE, G
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (02) : 475 - 479
  • [5] UTILIZATION OF THE BETA-CHAIN AND GAMMA-CHAIN OF THE IL-2 RECEPTOR BY THE NOVEL CYTOKINE-IL-15
    GIRI, JG
    AHDIEH, M
    EISENMAN, J
    SHANEBECK, K
    GRABSTEIN, K
    KUMAKI, S
    NAMEN, A
    PARK, LS
    COSMAN, D
    ANDERSON, D
    [J]. EMBO JOURNAL, 1994, 13 (12) : 2822 - 2830
  • [6] HARADA N, 1992, J BIOL CHEM, V267, P22752
  • [7] HE YW, 1995, J IMMUNOL, V155, P9
  • [8] AN INTERLEUKIN-4-INDUCED TRANSCRIPTION FACTOR - IL-4 STAT
    HOU, JZ
    SCHINDLER, U
    HENZEL, WJ
    HO, TC
    BRASSEUR, M
    MCKNIGHT, SL
    [J]. SCIENCE, 1994, 265 (5179) : 1701 - 1706
  • [9] JAKS AND STATS IN SIGNALING BY THE CYTOKINE RECEPTOR SUPERFAMILY
    IHLE, JN
    KERR, IM
    [J]. TRENDS IN GENETICS, 1995, 11 (02) : 69 - 74
  • [10] IZUHARA K, 1993, J BIOL CHEM, V268, P13097